Nevertheless, compelling clinical and experimental evidence support the importance of IFN-β production by tumor cells themselves in mediating antitumor responses to radiation therapy in combination with immune checkpoint inhibitors46–48. The gene discussed is IFNB1; the disease is neoplasm.